Overview

Ketogenic Diet in Infants With Epilepsy (KIWE)

Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Epilepsy, a condition where individuals are prone to recurrent epileptic seizures, is the most common chronic neurological disorder in children. Epilepsy onset is most common in the first two years of life and is associated with poor prognosis for seizure control and neurodevelopmental outcome. The ketogenic diet (KD) is a medically supervised diet that is high in fat and restricted in carbohydrates and protein. KD therapy has shown to be an effective treatment for seizures in children with epilepsy older than two. Associated benefits include: a reduced requirement for routine and emergency antiepileptic drugs (AED) and fewer seizure related hospital admissions. Although reports suggest that KD therapy improves seizures in younger children there is no high quality trial data that demonstrates effectiveness and safety in this age group. The KD is resource intensive, requiring dietetic and physician time; data is required to justify expansion of services to cater for the apparent need. The investigators therefore propose a prospective multicentre randomised trial to investigate the effectiveness and safety of the KD in children with epilepsy under the age of 2, who have failed to respond to two or more AEDs. Children will be randomly assigned to either receive the KD or further AEDs. The allocated treatment will be started after a 2week baseline period, and it's effectiveness assessed after 8 weeks. Seizure diaries will be used to record seizures and related events, a questionnaire will be used to assess diet tolerance; also growth and blood biochemistry will be monitored. The information obtained from this study is necessary to optimise choices in epilepsy treatment, aiming to improve outcomes and thus determine whether and when the KD should should be used.
Phase:
Phase 4
Details
Lead Sponsor:
University College, London
Collaborators:
Alder Hey Children's NHS Foundation Trust
Birmingham Children's Hospital NHS Foundation Trust
Birmingham Women's and Children's NHS Foundation Trust
Bristol Royal Hospital for Children
Cambridge University Hospitals NHS Foundation Trust
Central Manchester University Hospitals NHS Foundation Trust
Great Ormond Street Hospital for Children NHS Foundation Trust
Guy's and St Thomas' NHS Foundation Trust
Lancashire Care NHS Foundation Trust
Manchester University NHS Foundation Trust
Matthew's Friends
National Institute for Health Research, United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
Sheffield Children's NHS Foundation Trust
St George's University Hospitals NHS Foundation Trust
The Leeds Teaching Hospitals NHS Trust
Treatments:
Anticonvulsants
Carbamazepine
Clobazam
Clonazepam
Ethosuximide
Lamotrigine
Levetiracetam
Nitrazepam
Phenytoin
Rufinamide
Stiripentol
Topiramate
Valproic Acid
Vigabatrin
Zonisamide